Argenica Therapeutics Ltd Cash Flow Quality Index

Latest as of December 2020: -3.94x

Argenica Therapeutics Ltd cash flow quality index. Argenica Therapeutics Ltd (AGN) has a Cash Flow Quality Index of -3.94x as of December 2020. Operating cash flow of AU$-256.95K is below net income of AU$65.24K, suggesting accrual-heavy earnings not yet converted to cash. See Argenica Therapeutics Ltd (AGN) flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-3.94x
Operating CF / Net Income

Operating Cash Flow

AU$-256.95K
AUD

Net Income

AU$65.24K
AUD

Data as of

Dec 2020
Most recent filing

Argenica Therapeutics Ltd Cash Flow Quality Index by Year (None–None)

Argenica Therapeutics Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Argenica Therapeutics Ltd. For the full cash flow conversion analysis, see Argenica Therapeutics Ltd (AGN) cash flow conversion.

Year Quality Index Operating CF (AUD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.